IgG Subclasses Against Helicobacter pylori Isolates: An important Tool for Disease Characterization-Reference-Cited by-同舟云学术

IgG Subclasses Against Helicobacter pylori Isolates: An important Tool for Disease Characterization

Published:2012-06-12 Issue:1 Volume:76 Page:26-32
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:

Author:

Martínez-Becerra F.,Castillo-Rojas G.,de León S. Ponce,López-Vidal Y.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3083.2012.02699.x/fullpdf

Reference22 articles.

1. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration;Marshall;Lancet,1984

2. Helicobacter pylori phenotypes associated with peptic ulceration;Blaser;Scand J Gastroenterol Suppl,1994

3. Parasitism by the “slow” bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia;Blaser;J Clin Invest,1994

4. Host-bacterial interactions in Helicobacter pylori infection;Amieva;Gastroenterology,2008

5. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. Lyon, 7-14 June 1994;IARC Monogr Eval Carcinog Risks Hum,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express-ureF DNA Vaccines;Archivum Immunologiae et Therapiae Experimentalis;2024-01-01

2. Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma;Cancer Biology & Therapy;2019-02-20

3. Association of host immunity with Helicobacter pylori infection in recurrent gastric cancer;Infectious Agents and Cancer;2019-02-11

4. T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection;Microbial Pathogenesis;2018-03

5. Gastric cancer progression associated with local humoral immune responses;BMC Cancer;2015-11-21